The Inherited Cancer Connect (Icon) Partnership

Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice

B Meiser, R Kaur, A Morrow, M Peate, WKT Wong, E McPike, E Cops, C Nichols, R Austin, M Fine, L Thrupp, R Ward, F Macrae, JE Hiller, AH Trainer, G Mitchell, R Susman, N Pachter, A Goodwin, PA James

2021-12-01

Background: This nationwide study assessed the impact of nationally agreed cancer genetics guidelines on use of BRCA1/2 germline t..

Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics

B Meiser, R Kaur, J Kirk, A Morrow, M Peate, WKT Wong, E McPike, E Cops, C Dowson, R Austin, M Fine, L Thrupp, R Ward, F Macrae, JE Hiller, AH Trainer, G Mitchell, R Susman, N Pachter, A Goodwin

2020-10-01

Introduction: This nationwide study assessed the impact of Lynch syndrome-related risk management guidelines on clinicians’ recomm..

Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers

L Mascarenhas, S Shanley, G Mitchell, AB Spurdle, F Macrae, N Pachter, DD Buchanan, RL Ward, S Fox, E Duxbury, R Driessen, A Boussioutas

2018-12-01

Aim & Methods: An electronic survey of the Royal College of Pathologists of Australasia accredited pathology services was conducte..